Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan

Go back to Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
(NASDAQ: PULM) Delayed: 1.54 +0.08 (5.48%)
Previous Close $1.46    52 Week High $5.56 
Open $1.46    52 Week Low $0.76 
Day High $1.62    P/E N/A 
Day Low $1.41    EPS $0.00 
Volume 175,630